KDM1A and liver cancer: Moreover, our bioinformatic analysis reveals LSD1 transcripts are overexpressed in liver cancer in comparison with normal liver tissues which may provide a potent explanation why the clinical use of Lenvatinib is limited and further support the clinical value of our study.